SHENZHEN DUOTEBANG TECHNOLOGY INNOVATION CO.,LTD – Trademark Portfolio
Entity Type: 16
SHENZHEN DUOTEBANG TECHNOLOGY INNOVATION CO.,LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ZZN. The owner is based in SHENZHEN.
3B01-20, BUILDING A1, 1983 CREATIVE
TOWN,, 29 NANXIN STREET, NANLING VILLAGECOMMUNITY, NANWAN STREET, LONGGANG DISTRICT,
SHENZHEN 511464 , CN
Showing of trademarks Trademarks
Trademark Classifications
SHENZHEN DUOTEBANG TECHNOLOGY INNOVATION CO.,LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does SHENZHEN DUOTEBANG TECHNOLOGY INNOVATION CO.,LTD have?
SHENZHEN DUOTEBANG TECHNOLOGY INNOVATION CO.,LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does SHENZHEN DUOTEBANG TECHNOLOGY INNOVATION CO.,LTD file in?
SHENZHEN DUOTEBANG TECHNOLOGY INNOVATION CO.,LTD files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are SHENZHEN DUOTEBANG TECHNOLOGY INNOVATION CO.,LTD's most well-known trademarks?
SHENZHEN DUOTEBANG TECHNOLOGY INNOVATION CO.,LTD's registered trademark portfolio includes well-known marks such as ZZN. These are among 1 currently registered trademark in the portfolio.
What is SHENZHEN DUOTEBANG TECHNOLOGY INNOVATION CO.,LTD's trademark registration success rate?
SHENZHEN DUOTEBANG TECHNOLOGY INNOVATION CO.,LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.